Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 223-233

  Nyyssönen, Kristiina ^a   Porkkala Sarataho, Elina ^a   Kaikkonen, Jari ^a   Salonen, Jukka T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

antioxidant; ascorbic acid; lipoprotein oxidation; urate

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; URATE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CHOLESTEROL; COPPER; FEMALE; FINLAND; FREE RADICALS; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; SMOKING; TRIGLYCERIDES; URIC ACID; VITAMIN A; VITAMIN E;

EID: 0343247737     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06064-9     Document Type: Article

References (56)

1. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
2. Salonen JT. Epidemiological studies on LDL oxidation, pro- and antioxidants and atherosclerosis. In: Bellomo G, Finardi G, Maggi E and Rice-Evans C (EDS). Free Radicals, Lipoprotein oxidation and Atherosclerosis. Biological and Clinical Aspects. London: Richelieu Press, 1995;27-52.
3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996;20:707-727.
4. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-1095.
5. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Krpela H, Salonen R, Nyyssönen K, Palinski W, Witztum, JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-887.
6. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxiation of human low density lipoprotein. Free Rad Res Comms 1989;6:67-75.
7. Belcher JC, Balla J, Balla G, Jacobs DR, Gross M, Jacob HS, Vercellotti GM. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993;13:1779-1789.
8. Nyyssönen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistace of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 1994;48:633-642.
9. Regnström J, Ström K, Moldeus P, Nilson J. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Rad Res Comms 1993;19:267-278.
10. Schnitzer E, Pinchuk I, Fainaru M, Schafer Z, Lichtenberg D. Copper-induced lipid oxidation in unfractionated plasma: the lag precending oxidation as a measure of oxidation-resistance. Biochem Biophys Res Commun 1995;216:854-861.
11. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341-390.
12. Bowry VW, Mohr D, Cleary J, Stocker, R. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 1995;270:5756-5763.
13. Wayner DDM., Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS 1985;187:33-37.
14. Metsä-Ketelä T. Luminescent assay for total peroxyl radical-trapping capability of plasma. In: Stanley P and Kricka L (EDS). Bioluminescence and chemiluminescence current status. Chichester: John Wiley, 1991;389-392.
15. Whitehead TP, Thorpe GHG, Maxwell SRJ. Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992;266:265-277.
16. Lissi E, Salim-Hanna M, Pascual C, del Castillo MD. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Rad Biol Med 1955;18:153-158.
17. Uotila JT, Kirkkola A-L, Rorarius M, Tuimala R, Metsä-Ketelä, T. The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. Free Rad Biol Med 1994;16:581-590.
18. Porkkala-Sarataho, E, Nyyssönen, K, Salonen, JT. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men. Atherosclerosis 1996;124:83-94.
19. Nyyssönen K, Pikkarainen S, Parviainen MT, Heinonen, K, Monoen I. Quantitative estimation of ascorbic acid and dehydroascorbic acid by high-performance liquid chromatography - application to human milk, plasma and leukocytes. J Liq Chromatogr 1988;11:1717-1728.
20. Baker M, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione disulfide in large numbers of biological samples. Anal Biochem 1990;190:360-365.
21. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:770-776.
22. 2+/dextran sulfate in its enzymic measurement. Clin Chem 1978;26:931-933.
23. SPSS Inc. SPSS Reference Guide. Chicago: SPSS Inc, 1990.
24. Salonen JT, Nyyssönen K, Tuomainen T-P, Mäenpää PH, Krpela H, Kaplan GA, Lynch J, Helmrich S, Salonen R. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. Br Med J 1995;311:1124-1127.
25. Jordan P, Brubacher D, Moser U, Stähelin HB, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem 1995;41:924-927.
26. Reaven P, Witztum J. Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility of oxidation. Arterioscler Thromb 1993;13:601-608.
27. Jialal I, Fuller CJ, Huet, BA. The effect of α-tocopherol supplementation on LDL oxidation. A dose-responce study. Arterioscler Thromb Vasc Biol 1995;15:190-198.
28. Rifici VA, Khachadurian AK. Dietary supplemention with vitamins C and E inhibits in vitro oxidation of lipoproteins. J Am Coll Nutr 1993;12:631-637.
29. Fuller JF, Grundy, SM, Norkus EP, Jialal, I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996;119:139-150.
30. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci 1989;86:6377-6381.
31. Doba T, Graham WB, Ingold KU. Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta 1985;835:298-303.
32. Wayner DM, Burton GW, Ingold KU, Barclay LRC, Lcke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987;924:408-419.
33. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S-1118S.
34. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990;82:185-191.
35. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J Biol Chem 1993;268:1304-1309.
36. Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci 1992;89:10316-10320.
37. Becker BF. Towards the physiological function of uric acid. Free Rad Biol Med 1993;14:615-631.
38. Hochstein P, Hatch L, Sevanian A. Uric acid: functions and determination. Meth Enzymol 1984;105:162-166.
39. Sevanian A, Davies KJA, Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 1991;54:1129S-1134S.
40. Halliwell B, Gutteridge MC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
41. Shamsi FA, Hadi, SM. Photoinduction of strand scission in DNA by uric acid and Cu(II). Free Rad Biol Med 1995;19:189-196.
42. Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res 1988;48:2916-2918.
43. Kolonel LN, Yoshizawa, C, Nomura, AMY, Stemmermann, GN. Realationship of serum uric acid to cancer occurence in a prospective male cohort. Cancer Epidemiol 1994;3:225-228.
44. Suzukawa M, Ishikawa T, Yoshida H, Nakamura H. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 1995;14:46-52.
45. Nishigaki I, Hagihara M, Tsunekawa H, Maseki, M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981;25:373-378.
46. Maseki M, Nishigaki I, Hagihara M, Tomoda T, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981;115:155-161.
47. D'Aquino M, Dunster C, Willson RL. Vitamin A and glutathione-mediated free radical damage: competing reactions with polyunsaturated fatty acids and vitamin C. Biochem Biophys Res Comm 1989;161:1199-1203.
48. Livrea MA, Tesoriere L, Bongiorno A, Pintaudi, A.M., Ciaccio M, Riccio A. Contribution of vitamin A to the oxidation resistance of human low density lipoproteins. Free Rad Biol Med 1995;18:401-409.
49. Tesoriere L, Bongiorno A, Pintaudi AM, D'Anna R, D'Arpa D, Livrea, MA. Synergistic interactions between vitamin A and vitamin E against peroxidation in phosphatidylcholine liposomes. Arch Biochem Biophys 1996;236:57-63.
50. Eiserich JP, Van der Vliet A, Handelman GJ, Halliwell B. Cross CE Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995;62:1490S-1500S.
51. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health 1989;79:158-162.
52. Lykkesfeldt J, Priemé H, Loft S, Poulsen HE. Effect of smoking cessation on plasma ascorbic acid concentration. BMJ 1996;313:91.
53. Duthie GG, Arthur JR, James PT. Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 1991;53:1061S-1063S.
54. Mezzetti A, Lapenna D, Pierdomenico SD., Calafiore AM, Costanini AM, Riario-Sforza G, Imbastaro T, Neri M, Cuccurullo F. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 1995;112:91-99.
55. Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: basel prospective study. Clin Investig 1993;71:3-6.
56. Kritchevsky SB, Shimakawa T, Tell GS, Dennis, B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, Heiss G. Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Circulation 1995;92:2142-2150.